N-methyl-[11C]2-(4′-methylaminophenyl)-6-hydroxybenzothiazole, better known as Pittsburgh Compound B (or simply PIB), has been long anticipated in Alzheimer's disease circles. The PET radiotracer allows researchers and clinicians to see amyloid plaque deposition in live human subjects, opening up a number of investigational and clinical possibilities.